Innovative Solutions
We develop cutting-edge thrombolytic therapeutics tailored to patient needs.
We develop cutting-edge thrombolytic therapeutics tailored to patient needs.
Our therapies prioritize minimizing severe bleeding risks effectively.
Our professionals drive advancements in thrombolytic technology.
Committed to improving outcomes for thromboembolic condition patients.
Thrombolytic therapy involves administering drugs to dissolve blood clots that can cause severe cardiovascular conditions such as strokes and heart attacks.
We develop novel thrombolytic agents aimed at effectively
dissolving clots while significantly reducing the risk of severe bleeding complications associated with traditional therapies.
We focus on thromboembolic conditions, including ischemic stroke, myocardial infarction, deep vein thrombosis, and pulmonary embolism.
You can reach us at 5 Cedarbrook Dr STZ 2, Cranbury, NJ, or call (267) 307-5188 during business hours.